Judith M. White

This study evaluates combinations of approved oral nucleoside analogues against multiple alphaviruses in vitro and in vivo, finding synergistic antiviral effects and reduced viral mutation rates with combination therapy.

The paper identifies host proteins modulating SARS-CoV-2 infection by expanding the virus-host protein interaction network and testing chemical inhibitors of these targets.